Rukmini Prameya
University of British Columbia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rukmini Prameya.
Journal of Neuropathology and Experimental Neurology | 1999
Donald Wong; Rukmini Prameya; Katerina Dorovini-Zis
Increased lymphocyte traffic across an altered blood-brain barrier (BBB) is a prominent and early event in inflammatory and immune-mediated CNS diseases. The factors that control the entry of lymphocytes into the brain have not been fully elucidated. In this study, primary cultures of human brain microvessel endothelial cells (HBMEC) were used to investigate the role of endothelial cell (EC) adhesion molecules in the adhesion and migration of peripheral blood T lymphocytes across TNF-alpha treated and untreated monolayers. Adhesion of T cells to unstimulated HBMEC was minimal and few of the adherent cells migrated across the monolayers. Treatment of HBMEC with TNF-alpha augmented adhesion by 5-fold. The binding to activated EC was significantly, but not completely, inhibited by monoclonal antibodies (mAbs) to ICAM-1 and VCAM-1, whereas adhesion to unstimulated EC was blocked by mAb to ICAM-1 but not VCAM-1. Transendothelial migration of lymphocytes increased by up to 30-fold following treatment of HBMEC with TNF-alpha. Migration across activated monolayers, but not across untreated EC, was almost completely blocked by Ab to ICAM-1 and significantly inhibited by Abs to PECAM-1 and E-selectin. VCAM-1 was not utilized during transendothelial migration. Ultrastructurally, pseudopodia from lymphocytes contacted finger-like cytoplasmic projections on EC and eventually penetrated the EC cytoplasm at focal points along the apical surface. Migrating lymphocytes moved either through the EC cytoplasm or between adjacent EC across intercellular contacts. The overlying monolayers showed no evidence of disruption and intercellular junctions appeared intact over the migrated T cells. These studies indicate that adhesion and migration of T lymphocytes across the cerebral endothelial barrier are distinct processes that depend upon the activation state of EC and are controlled by diverse receptor-ligand interactions.
Journal of Neuroimmunology | 2007
Donald Wong; Rukmini Prameya; Katerina Dorovini-Zis
The mechanisms by which polymorphonuclear leukocytes (PMN) cross the human blood-brain barrier have not been fully elucidated. Using a well characterized in vitro model of the human BBB, we examined the role of endothelial cell adhesion molecules on the adhesion and transendothelial migration of PMN across primary cultures of human brain microvessel endothelial cells (HBMEC). A small number of PMN (0.06%) adhered to unstimulated HBMEC, and the basal adhesion was not affected by anti-adhesion molecule antibodies. Treatment of HBMEC with tumor necrosis factor (TNF)-alpha resulted in increased PMN adhesion that was significantly inhibited by blocking antibodies to E-selectin and ICAM-1, but not VCAM-1 or PECAM-1. A very small number of adherent PMN migrated across unstimulated HBMEC monolayers. Migration increased 2 to 20 fold following stimulation of HBMEC with TNF-alpha. Monoclonal antibody blocking studies showed that PMN used ICAM-1, but not VCAM-1, E-selectin or PECAM-1 to move across activated monolayers. Anti-adhesion molecule antibodies did not diminish the basal PMN migration. Ultrastructurally, PMN often aggregated on top and between adjacent endothelial cells and adhered by first extending pseudopodia along the apical endothelial surface. They then flattened and inserted themselves between endothelial cells in order to migrate across the monolayers. At the end of the migration period, the cultures resumed their continuity with no evidence of disruption. Transendothelial migration of PMN decreased the transendothelial electrical resistance and increased the permeability to horseradish peroxidase, which penetrated alongside the migrating leukocytes. A blocking antibody to ICAM-1 that greatly decreased migration, had no effect on the permeability changes. These studies provide insights into the mechanisms that regulate the entry of PMN into the brain and the increased permeability of the BBB in CNS inflammation.
Journal of Neuropathology and Experimental Neurology | 1992
Katerina Dorovini-Zis; Phillip D. Bowman; Rukmini Prameya
Abstract. Adhesion and migration of human polymorphonuclear leukocytes (PMN) across cerebral endothelium were studied in an in vitro model consisting of monolayers of bovine brain microvessel endothelial cells (BBMEC) grown on amniotic stroma or collagen membranes. Polymorphonuclear leukocytes were stimulated to adhere to and migrate across confluent BBMEC monolayers in response to chemotactic gradients produced by formyl-methionyl-leucyl phenylalanine (fMLP), leukotriene B4 (LTB4) or acetyl-glyceryl-ether-phosphorylcholine (AGEPC) placed below the cultures. Under these conditions, PMN adherence to endothelium was 2–10-fold greater than that observed in the absence of chemoattractants or in the presence of equal concentrations of chemoattractants below and above the cultures. Transendothelial migration of PMN occurred rapidly and at focal points across the monolayers. Scanning and electron microscopic studies revealed that stimulated PMN migrated across the monolayers by first adhering to the apical surface of the endothelium and then moving between adjacent endothelial cells. Following their migration, PMN accumulated beneath the endothelium. The overlying endothelial monolayers showed no evidence of disruption and the interendothelial junctions appeared intact at the end of the migration period. We conclude that this in vitro system reproduces the endothelial cell-leukocyte interactions occurring during acute inflammation in vivo and should provide a useful in vitro model for studying the molecular mechanisms underlying these interactions in inflammatory diseases of the central nervous system.
Microvascular Research | 1999
Li Li; Brian Bressler; Rukmini Prameya; Katerina Dorovini-Zis; C. van Breemen
Biochemical and Biophysical Research Communications | 2004
Donald Wong; Rukmini Prameya; Katerina Dorovini-Zis; Steven R. Vincent
European Journal of Pharmacology | 2005
Donald Wong; Rukmini Prameya; Vivian Wu; Katerina Dorovini-Zis; Steven R. Vincent
Journal of Immunology | 2009
Jaya Talreja; Rukmini Prameya; Katerina Dorovini-Zis
The FASEB Journal | 2007
Azadeh Arjmandi; Vivian Wu; Rukmini Prameya; Katerina Dorovini-Zis
Journal of Neuropathology and Experimental Neurology | 2007
Azadeh Arjmandi; Vivian Wu; Rukmini Prameya; Katerina Dorovini-Zis
Journal of Neuropathology and Experimental Neurology | 1998
J. Shukaliak; Rukmini Prameya; Vivian Wu; Katerina Dorovini-Zis